El-Mezayen et al. utilized flow cytometry to identify CTCs (CK18 and CK19) and developed a novel score based on five biochemical blood markers (CK18, CK19, AFP, Albumin, Platelets) to predict HCC among HCV-high-risk patients [80]. Here, KRT19 is linked to hepatocellular carcinoma.